Loading Events
  • Home
  • |
  • Events
  • |
  • Conference: 7th Annual Biologics ...

Conference: 7th Annual Biologics Manufacturing Asia 2020

REGISTER FOR REGULAR UPDATES

Why you should attend Biologics Manufacturing Asia 2020

The biologics industry in Southeast Asia is estimated to be the fastest-growing market in the world. The key drivers motivating the growth of the biologics industry in Asia are competitive manufacturing costs, the increase in of high-skilled workers, new cell culture techniques, fast-track flexible GMP facilities equipped with disposables, attempts for integrated continuous manufacturing, combining modular facilities, single-use and other advances in the downstream processing of biologics.

While experiencing excellence in manufacturing processes, the industry is constantly reworking strategies and on the lookout for tools to overcome high-manufacturing complexities, expensive purification processes and other challenges across the bioprocessing value chain. Crucial aspects of the process and product characterisation, analytical method development amongst others support the manufacturing value chain and analytical technologies are being explored. Portfolios are expanding to include a heavier emphasis on regenerative medicine, particularly cell and gene therapy.

To facilitate brainstorming, strategy-generating discussions on the aforementioned key aspects of the biologics industry, IMAPAC is bringing to you 3 focus areas: Bio-Manufacturing, Bio-Analytics and Cell Therapy Bioprocessing as part of Asia’s biggest, most focussed annual bioprocessing conference, the 7th Annual Biologics Manufacturing Asia 2020.

  • 500+ high profile attendees
  • 150+ organisations
  • 80+ expert speakers
  • 20+ hours of networking

To view the speaker list for the event please click here.

Conference agenda

The 7th Annual Biologics Manufacturing World Asia is the largest and ONLY bioprocess business and technology convention in Southeast Asia. In 2020, 500+ biomanufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities, Solution Providers across Singapore, South Korea, Taiwan, Japan, Australia, India, South East Asia, Indo China, and China will convene to discover, discuss and debate on the best manufacturing practices to make better biologic drugs cheaper and faster.

Who is this event suitable for?

UK pharmaceutical companies with a vested interest in or currently exporting to ASEAN.

More information

To contact the event organisers, please use the contact details below.

133 Cecil Street, #05-02, Keck Seng Tower, Singapore 069535
7912 Makati Ave, Makati, Metro Manila, Philippines
info@imapac.com
+65 3109 0121

To find out more on the event website about the agenda, attendance prices, sponsorship opportunities, download the event brochure and much more, please click the link below.

 

Read More

Event:

Website Register

Share this Event: